Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 7.00 (4.982%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 140.00
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Jan 2024 16:30

RNS Number : 4185B
Redcentric PLC
30 January 2024

Redcentric plc

Director/PDMR Shareholdings

Redcentric plc (AIM:RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, received notification from Kestrel Partners LLP ("Kestrel") that on 24 January 2024 and 26 January 2024 it purchased, on behalf of its discretionary client accounts, an aggregate of 19,000 ordinary shares of 0.1 pence each ("Ordinary Shares") in the Company at an average price of £1.2581 per Ordinary Share.

Mr Oliver Scott is a partner of, and holds a beneficial interest in, Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Redcentric.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 16,715,306 Ordinary Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest, hold 15,975,253 Ordinary Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 32,690,559 Ordinary Shares in the Company, which represents approximately 20.66 per cent of the total voting rights in the Company.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of Ordinary Shares

% of total voting rights

Indirect

Bank of New York Nominees Ltd

16,715,306

10.56%

Indirect

JIM Nominees Limited

464,310

0.29%

Indirect

Bank of New York Nominees Ltd

12,471,770

7.88%

Indirect

Northern Trust Company AVFC

3,039,173

1.93%

For further information contact:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

+44 (0) 800 983 2522

Cavendish Capital Markets Limited (NOMAD and Sole Broker)

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0) 20 7220 0500

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kestrel Partners LLP

2

Reason for the notification

a)

Position/status

PCA - Oliver Scott (non-executive director Redcentric plc)

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

0.1 pence Ordinary Shares

ISIN: GB00B7TW1V39

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Transfer

Purchase

24 January 2024

Price(s)

Volume(s)

£1.2558

6,000

26 January 2024

Price(s)

Volume(s)

£1.2592

13,000

d)

Aggregated information

- Aggregated volume

- Price

Purchase Total of 19,000 Ordinary Shares at a price of £1.2581

e)

Date of the transaction

24 January 2024 and 26 January 2024

f)

Place of the transaction

London AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBMMFTMTBJBAI
Date   Source Headline
7th Sep 20207:00 amRNSForm 8 (OPD) - Redcentric plc
4th Sep 20204:37 pmRNSForm 8.3 - Redcentric PLC
4th Sep 20209:08 amRNSForm 8.3 - Redcentric Plc
4th Sep 20208:55 amRNSForm 8.3 - Redcentric Plc
3rd Sep 20205:35 pmRNSForm 8.3 - Redcentric Plc
3rd Sep 20204:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
3rd Sep 20204:33 pmRNSForm 8.3 - Redcentric plc
3rd Sep 20201:15 pmRNSForm 8 (OPD) - Redcentric PLC
3rd Sep 202012:00 pmRNSForm 8.5 (EPT/RI) - Redcentric Plc
3rd Sep 20209:07 amRNSForm 8.3 - Redcentric PLC
3rd Sep 20208:30 amRNSRule 2.9 Announcement
2nd Sep 20207:00 amRNSResponse to press speculation-formal sales process
1st Sep 20208:30 amRNSRestitution Scheme Update
1st Sep 20207:00 amRNSSave As You Earn Share Option Scheme
24th Aug 202010:23 amRNSRestitution Scheme Update
17th Aug 20202:45 pmRNSRestitution Scheme Update
11th Aug 20207:00 amRNSPublication of Annual Report and Notice of AGM
11th Aug 20207:00 amRNSRestitution Scheme Update
29th Jul 20207:00 amRNSIssue of Equity and Total Voting Rights
21st Jul 20207:00 amRNSPreliminary Results Announcement FY20
13th Jul 20201:19 pmRNSGeneral Meeting Result, Voting Rights & Admission
26th Jun 202010:07 amRNSAdditional Voting Support
26th Jun 20207:00 amRNSProposed Restitution Scheme and Placing
26th Jun 20207:00 amRNSTrading Update and Results Date
19th Jun 20207:00 amRNSDelay of Full Year Results
9th Jun 20207:00 amRNSExtension of bank facilities
12th May 20203:22 pmRNSHolding(s) in Company
3rd Apr 20207:01 amRNSBoard Changes
3rd Apr 20207:00 amRNSTrading update and COVID-19 update
19th Mar 20205:48 pmRNSTransaction in Own Shares
17th Mar 20205:41 pmRNSTransaction in Own Shares
16th Mar 20205:15 pmRNSTransaction in Own Shares
27th Feb 20207:00 amRNSTransaction in Own Shares
13th Jan 20207:00 amRNSChange of Adviser
28th Nov 20197:00 amRNSHalf Year Results
20th Nov 20195:06 pmRNSTransaction in Own Shares
5th Nov 20195:02 pmRNSTransaction in Own Shares
30th Oct 20195:18 pmRNSTransaction in Own Shares
29th Oct 20197:00 amRNSTransaction in Own Shares
25th Oct 20195:23 pmRNSTransaction in Own Shares
17th Oct 20197:00 amRNSBoard Changes
9th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding and Issue of Equity
27th Sep 20195:57 pmRNSTransaction in Own Shares
17th Sep 20197:00 amRNSShare Buyback Programme
4th Sep 20192:30 pmRNSIssue of Options
2nd Sep 20191:03 pmRNSResult of AGM
30th Aug 20194:27 pmRNSDirector Shareholding
30th Aug 20194:19 pmRNSSave As You Earn Share Option Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.